Your session is about to expire
← Back to Search
Study Summary
This trial tests a new drug, ensifentrine, to see if it's effective in treating asthma. Patients will receive the drug and a placebo at different times during the study, and researchers will compare the results.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 763 Patients • NCT04535986Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are between 40 and 80 years old, have smoked at least 10 packs of cigarettes in your life, and have been diagnosed with COPD based on specific guidelines.You can use the jet nebulizer correctly and follow all study rules. You can do spirometry tests as instructed and provide sputum samples when needed.You have been diagnosed with a lung disease other than COPD, like asthma or cystic fibrosis. You have been hospitalized for COPD, pneumonia, or COVID-19 in the past 12 weeks, or you currently have an active COVID-19 infection. However, if you had a positive COVID-19 antibody test in the past and do not have any symptoms of an active infection, you can still participate in the study. If you had a positive COVID-19 test less than 30 days ago, you may be able to participate after waiting for 30 days or as per local requirements.You have abnormal heart rhythm or a history of heart problems. You are not suitable for the study if you have had bad reactions to certain medications or if you cannot use the study-supplied medication for COPD as directed.
- Group 1: Treatment Sequence 2
- Group 2: Treatment Sequence 1
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research include patients who are over 35 years old?
"This study is enrolling patients that are over 40 and under 80 years old."
Does Ensifentrine have any negative side effects?
"There is some evidence backing the safety of Ensifentrine, as this drug is in Phase 2 of clinical trials. However, there is no data currently suggesting that it is an effective medication."
Are people with the condition being sought for this research?
"From the information available on clinicaltrials.gov, it can be inferred that this study is looking for more participants. The first posting was on 5/27/2022 and the last update was 8/26/2022."
How many people are receiving therapy in this experiment?
"Yes, the information available on clinicaltrials.gov shows that this trial is currently recruiting patients. The trial was first posted on May 27, 2022 and was last updated on August 26, 2022. The study is looking for 40 patients across 1 site."
How can I become eligible for this research program?
"Eligible patients for this clinical trial must suffer from chronic obstructive airway disease, be 40 to 80 years old, and not have any other major health concerns. Roughly 40 people will be enrolled in the study."
Share this study with friends
Copy Link
Messenger